Global Histoplasmosis Treatment Market Research Report 2022

SKU ID : QYR-21348554 | Publishing Date : 18-Jul-2022 | No. of pages : 80

Request a free Sample

Detailed TOC of Global Histoplasmosis Treatment Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Histoplasmosis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Amphotericin B
        1.2.3 Itraconazole
        1.2.4 Ketoconazole
        1.2.5 Other
    1.3 Market by Distribution Channel
        1.3.1 Global Histoplasmosis Treatment Market Share by Distribution Channel: 2017 VS 2021 VS 2028
        1.3.2 Hospitals Pharmacies
        1.3.3 Drug stores and retail pharmacy
        1.3.4 E-commerce
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Histoplasmosis Treatment Market Perspective (2017-2028)
    2.2 Histoplasmosis Treatment Growth Trends by Region
        2.2.1 Histoplasmosis Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Histoplasmosis Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Histoplasmosis Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Histoplasmosis Treatment Market Dynamics
        2.3.1 Histoplasmosis Treatment Industry Trends
        2.3.2 Histoplasmosis Treatment Market Drivers
        2.3.3 Histoplasmosis Treatment Market Challenges
        2.3.4 Histoplasmosis Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Histoplasmosis Treatment Players by Revenue
        3.1.1 Global Top Histoplasmosis Treatment Players by Revenue (2017-2022)
        3.1.2 Global Histoplasmosis Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Histoplasmosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Histoplasmosis Treatment Revenue
    3.4 Global Histoplasmosis Treatment Market Concentration Ratio
        3.4.1 Global Histoplasmosis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Histoplasmosis Treatment Revenue in 2021
    3.5 Histoplasmosis Treatment Key Players Head office and Area Served
    3.6 Key Players Histoplasmosis Treatment Product Solution and Service
    3.7 Date of Enter into Histoplasmosis Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Histoplasmosis Treatment Breakdown Data by Type
    4.1 Global Histoplasmosis Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Histoplasmosis Treatment Forecasted Market Size by Type (2023-2028)
5 Histoplasmosis Treatment Breakdown Data by Distribution Channel
    5.1 Global Histoplasmosis Treatment Historic Market Size by Distribution Channel (2017-2022)
    5.2 Global Histoplasmosis Treatment Forecasted Market Size by Distribution Channel (2023-2028)
6 North America
    6.1 North America Histoplasmosis Treatment Market Size (2017-2028)
    6.2 North America Histoplasmosis Treatment Market Size by Country (2017-2022)
    6.3 North America Histoplasmosis Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Histoplasmosis Treatment Market Size (2017-2028)
    7.2 Europe Histoplasmosis Treatment Market Size by Country (2017-2022)
    7.3 Europe Histoplasmosis Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Histoplasmosis Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Histoplasmosis Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Histoplasmosis Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Histoplasmosis Treatment Market Size (2017-2028)
    9.2 Latin America Histoplasmosis Treatment Market Size by Country (2017-2022)
    9.3 Latin America Histoplasmosis Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Histoplasmosis Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Histoplasmosis Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Histoplasmosis Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bristol Myers Squibb
        11.1.1 Bristol Myers Squibb Company Detail
        11.1.2 Bristol Myers Squibb Business Overview
        11.1.3 Bristol Myers Squibb Histoplasmosis Treatment Introduction
        11.1.4 Bristol Myers Squibb Revenue in Histoplasmosis Treatment Business (2017-2022)
        11.1.5 Bristol Myers Squibb Recent Development
    11.2 Sigma tau pharmaceuticals Inc.
        11.2.1 Sigma tau pharmaceuticals Inc. Company Detail
        11.2.2 Sigma tau pharmaceuticals Inc. Business Overview
        11.2.3 Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Introduction
        11.2.4 Sigma tau pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2017-2022)
        11.2.5 Sigma tau pharmaceuticals Inc. Recent Development
    11.3 Three rivers pharmaceuticals
        11.3.1 Three rivers pharmaceuticals Company Detail
        11.3.2 Three rivers pharmaceuticals Business Overview
        11.3.3 Three rivers pharmaceuticals Histoplasmosis Treatment Introduction
        11.3.4 Three rivers pharmaceuticals Revenue in Histoplasmosis Treatment Business (2017-2022)
        11.3.5 Three rivers pharmaceuticals Recent Development
    11.4 Astellas pharma US Inc.
        11.4.1 Astellas pharma US Inc. Company Detail
        11.4.2 Astellas pharma US Inc. Business Overview
        11.4.3 Astellas pharma US Inc. Histoplasmosis Treatment Introduction
        11.4.4 Astellas pharma US Inc. Revenue in Histoplasmosis Treatment Business (2017-2022)
        11.4.5 Astellas pharma US Inc. Recent Development
    11.5 Abbott laboratories
        11.5.1 Abbott laboratories Company Detail
        11.5.2 Abbott laboratories Business Overview
        11.5.3 Abbott laboratories Histoplasmosis Treatment Introduction
        11.5.4 Abbott laboratories Revenue in Histoplasmosis Treatment Business (2017-2022)
        11.5.5 Abbott laboratories Recent Development
    11.6 Abraxis pharmaceutical products
        11.6.1 Abraxis pharmaceutical products Company Detail
        11.6.2 Abraxis pharmaceutical products Business Overview
        11.6.3 Abraxis pharmaceutical products Histoplasmosis Treatment Introduction
        11.6.4 Abraxis pharmaceutical products Revenue in Histoplasmosis Treatment Business (2017-2022)
        11.6.5 Abraxis pharmaceutical products Recent Development
    11.7 Teva parenteral medicines Inc.
        11.7.1 Teva parenteral medicines Inc. Company Detail
        11.7.2 Teva parenteral medicines Inc. Business Overview
        11.7.3 Teva parenteral medicines Inc. Histoplasmosis Treatment Introduction
        11.7.4 Teva parenteral medicines Inc. Revenue in Histoplasmosis Treatment Business (2017-2022)
        11.7.5 Teva parenteral medicines Inc. Recent Development
    11.8 X gen pharmaceuticals Inc.
        11.8.1 X gen pharmaceuticals Inc. Company Detail
        11.8.2 X gen pharmaceuticals Inc. Business Overview
        11.8.3 X gen pharmaceuticals Inc. Histoplasmosis Treatment Introduction
        11.8.4 X gen pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2017-2022)
        11.8.5 X gen pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Histoplasmosis Treatment Market Research Report 2022

List of Tables
    Table 1. Global Histoplasmosis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Amphotericin B
    Table 3. Key Players of Itraconazole
    Table 4. Key Players of Ketoconazole
    Table 5. Key Players of Other
    Table 6. Global Histoplasmosis Treatment Market Size Growth by Distribution Channel (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Histoplasmosis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Histoplasmosis Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Histoplasmosis Treatment Market Share by Region (2017-2022)
    Table 10. Global Histoplasmosis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Histoplasmosis Treatment Market Share by Region (2023-2028)
    Table 12. Histoplasmosis Treatment Market Trends
    Table 13. Histoplasmosis Treatment Market Drivers
    Table 14. Histoplasmosis Treatment Market Challenges
    Table 15. Histoplasmosis Treatment Market Restraints
    Table 16. Global Histoplasmosis Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Histoplasmosis Treatment Market Share by Players (2017-2022)
    Table 18. Global Top Histoplasmosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Histoplasmosis Treatment as of 2021)
    Table 19. Ranking of Global Top Histoplasmosis Treatment Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Histoplasmosis Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Histoplasmosis Treatment Product Solution and Service
    Table 23. Date of Enter into Histoplasmosis Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Histoplasmosis Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Histoplasmosis Treatment Revenue Market Share by Type (2017-2022)
    Table 27. Global Histoplasmosis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Histoplasmosis Treatment Revenue Market Share by Type (2023-2028)
    Table 29. Global Histoplasmosis Treatment Market Size by Distribution Channel (2017-2022) & (US$ Million)
    Table 30. Global Histoplasmosis Treatment Revenue Market Share by Distribution Channel (2017-2022)
    Table 31. Global Histoplasmosis Treatment Forecasted Market Size by Distribution Channel (2023-2028) & (US$ Million)
    Table 32. Global Histoplasmosis Treatment Revenue Market Share by Distribution Channel (2023-2028)
    Table 33. North America Histoplasmosis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Histoplasmosis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Histoplasmosis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Histoplasmosis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Histoplasmosis Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Histoplasmosis Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Histoplasmosis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Histoplasmosis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Histoplasmosis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Histoplasmosis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Bristol Myers Squibb Company Detail
    Table 44. Bristol Myers Squibb Business Overview
    Table 45. Bristol Myers Squibb Histoplasmosis Treatment Product
    Table 46. Bristol Myers Squibb Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million)
    Table 47. Bristol Myers Squibb Recent Development
    Table 48. Sigma tau pharmaceuticals Inc. Company Detail
    Table 49. Sigma tau pharmaceuticals Inc. Business Overview
    Table 50. Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Product
    Table 51. Sigma tau pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million)
    Table 52. Sigma tau pharmaceuticals Inc. Recent Development
    Table 53. Three rivers pharmaceuticals Company Detail
    Table 54. Three rivers pharmaceuticals Business Overview
    Table 55. Three rivers pharmaceuticals Histoplasmosis Treatment Product
    Table 56. Three rivers pharmaceuticals Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million)
    Table 57. Three rivers pharmaceuticals Recent Development
    Table 58. Astellas pharma US Inc. Company Detail
    Table 59. Astellas pharma US Inc. Business Overview
    Table 60. Astellas pharma US Inc. Histoplasmosis Treatment Product
    Table 61. Astellas pharma US Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million)
    Table 62. Astellas pharma US Inc. Recent Development
    Table 63. Abbott laboratories Company Detail
    Table 64. Abbott laboratories Business Overview
    Table 65. Abbott laboratories Histoplasmosis Treatment Product
    Table 66. Abbott laboratories Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million)
    Table 67. Abbott laboratories Recent Development
    Table 68. Abraxis pharmaceutical products Company Detail
    Table 69. Abraxis pharmaceutical products Business Overview
    Table 70. Abraxis pharmaceutical products Histoplasmosis Treatment Product
    Table 71. Abraxis pharmaceutical products Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million)
    Table 72. Abraxis pharmaceutical products Recent Development
    Table 73. Teva parenteral medicines Inc. Company Detail
    Table 74. Teva parenteral medicines Inc. Business Overview
    Table 75. Teva parenteral medicines Inc. Histoplasmosis Treatment Product
    Table 76. Teva parenteral medicines Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million)
    Table 77. Teva parenteral medicines Inc. Recent Development
    Table 78. X gen pharmaceuticals Inc. Company Detail
    Table 79. X gen pharmaceuticals Inc. Business Overview
    Table 80. X gen pharmaceuticals Inc. Histoplasmosis Treatment Product
    Table 81. X gen pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million)
    Table 82. X gen pharmaceuticals Inc. Recent Development
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Histoplasmosis Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Amphotericin B Features
    Figure 3. Itraconazole Features
    Figure 4. Ketoconazole Features
    Figure 5. Other Features
    Figure 6. Global Histoplasmosis Treatment Market Share by Distribution Channel in 2021 & 2028
    Figure 7. Hospitals Pharmacies Case Studies
    Figure 8. Drug stores and retail pharmacy Case Studies
    Figure 9. E-commerce Case Studies
    Figure 10. Other Case Studies
    Figure 11. Histoplasmosis Treatment Report Years Considered
    Figure 12. Global Histoplasmosis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Histoplasmosis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Histoplasmosis Treatment Market Share by Region: 2021 VS 2028
    Figure 15. Global Histoplasmosis Treatment Market Share by Players in 2021
    Figure 16. Global Top Histoplasmosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Histoplasmosis Treatment as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Histoplasmosis Treatment Revenue in 2021
    Figure 18. North America Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Histoplasmosis Treatment Market Share by Country (2017-2028)
    Figure 20. United States Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Histoplasmosis Treatment Market Share by Country (2017-2028)
    Figure 24. Germany Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Histoplasmosis Treatment Market Share by Region (2017-2028)
    Figure 32. China Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Histoplasmosis Treatment Market Share by Country (2017-2028)
    Figure 40. Mexico Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Histoplasmosis Treatment Market Share by Country (2017-2028)
    Figure 44. Turkey Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Bristol Myers Squibb Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022)
    Figure 47. Sigma tau pharmaceuticals Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022)
    Figure 48. Three rivers pharmaceuticals Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022)
    Figure 49. Astellas pharma US Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022)
    Figure 50. Abbott laboratories Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022)
    Figure 51. Abraxis pharmaceutical products Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022)
    Figure 52. Teva parenteral medicines Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022)
    Figure 53. X gen pharmaceuticals Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed

Keyplayers in Global Histoplasmosis Treatment Market Research Report 2022

Bristol Myers Squibb
Sigma tau pharmaceuticals Inc.
Three rivers pharmaceuticals
Astellas pharma US Inc.
Abbott laboratories
Abraxis pharmaceutical products
Teva parenteral medicines Inc.
X gen pharmaceuticals Inc.